Multifocal encephalopathy and autoimmune-mediated limbic encephalitis following tocilizumab therapy
Yuko Yamaguchi1, Koji Furukawa, Toru Yamamoto
1Department of Neurology, Osaka Saiseikai Nakatsu Hospital, Japan.
Abstract:
A 63-year-old man with rheumatoid arthritis developed multifocal encephalopathy and limbic encephalitis following therapy with tocilizumab, a humanized anti-interleukin-6 receptor antibody. Anti-glutamate receptor ε2 antibodies were later found to be positive in both the serum and cerebrospinal fluid. This case highlights the possibility of the development of encephalopathy after treatment with tocilizumab, which may also induce autoimmune limbic encephalitis.
Related Concept Videos
Encephalitis l: Introduction
Encephalitis ll: Pathophysiology
Multiple Sclerosis l: Introduction
Autoimmune Disorders
Concept and Mechanism of Autoimmune Diseases
The immune...
Cytotoxic Edema: Pathophysiology
Hypersensitivity Reactions: Immune-Complex Reactions


